Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy

The American Journal of Medicine

Volumn 84, Issue 1, 1988, Pages 94-100

  Leport, Catherine ^a   Raffi, Francois ^a   Matheron, Sophie ^a   Katlama, Christine ^a   Regnier, Bernard ^a   Saimot, Adrien G ^a   Marche, Claudie ^a   Vedrenne, Claude ^a   Vilde, Jean Louis ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PYRIMETHAMINE; SULFADIAZINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL ARTICLE; HUMAN; TOXOPLASMOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CENTRAL NERVOUS SYSTEM DISEASES; DRUG THERAPY, COMBINATION; FEMALE; HUMAN; MALE; PYRIMETHAMINE; SULFADIAZINE; TIME FACTORS; TOXOPLASMOSIS;

EID: 0023934097     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(88)90014-9     Document Type: Article

References (29)

1. Toxoplasmosis in the compromised host
2. Acquired toxoplasmosis
3. Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome
4. A comparative study of some combined treatment regimens in acute toxoplasmosis in mice
5. An evaluation of the curative effects of pyrimethamine and sulfadiazine, alone and in combination, on experimental mouse toxoplasmosis
6. Effect of clindamycin on acute and chronic toxoplasmosis in mice
7. The effect of trimethoprim and sulfamethoxazole on Toxoplasma gondii in vitro and in vivo
8. Effects of pyrimethamine and sulfadiazine on the fine structure and multiplication of Toxoplasma gondii in cell cultures
9. New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole and cyclosporin A
10. Treating toxoplasmosis
11. Revision of the case definition of acquired immunodeficiency syndrome for national reporting—United States
12. Outbreak of central nervous system toxoplasmosis in Western Europe and North America
13. Cerebral toxoplasmosis complicating the acquired immunodeficiency syndrome: clinical and neuropathological findings in 27 patients
14. Central nervous system toxoplasmosis in homosexual men and parenteral drug abusers
15. Toxoplasma encephalitis in Haitian adults with acquired immunodeficiency syndrome: a clinical-pathologic-CT correlation
16. Intracerebral toxoplasmosis in patients with acquired immune deficiency syndrome
17. Coloration des fibres nerveuses par la méthode à l'hématoxyline au fer après inclusion à la celloidine
18. Toxoplasma gondii infection of the central nervous system
19. Isolation of a new human retrovirus from West African patients with AIDS
20. Relative reversal by vitamins (p-aminobenzoic, folic and folinic acids) of the effects of sulfadiazine and pyrimethamine on Toxoplasma in mouse and man
21. Trimethoprim and folinic acid (letter)
22. Clinical course of tissue documented cerebral toxoplasmosis in patients with acquired immune deficiency syndrome (AIDS)
23. Parasitic diseases in immunocompromised hosts
24. Toxoplasmosis
25. Diagnosis and treatment of pneumocystosis and toxoplasmosis in the immunosuppressed host
26. Toxoplasmosis in immunosuppression and AIDS
27. Prevention des accidents dus à l'utilisation de la pyriméthamine dans le traitement de la toxoplasmose
28. Complications of cotrimoxazole in treatment of AIDS-associated Pneumocystic carinii pneumonia in homosexual men
29. Failure of spiramycin to prevent neurotoxoplasmosis in immunosuppressed patients